Mandate

Vinge advises Eleda’s shareholders in connection with partnership with Altor

Vinge has advised the shareholders of Eleda Infra Services Group (“Eleda”) on the divestment of a majority stake in Eleda to Altor Fund V.

As part of the transaction, Eleda acquires and partners with the entrepreneurs of Järfälla VA- & Byggentreprenad AB and divests KEWAB, Kenneth Wahlström Aktiebolag. In addition, Eleda acquires ONE Nordic from Altor Fund III. Management of the respective companies will remain as significant shareholders of the combined group and continue in their respective operational management roles.

The new, larger, Eleda will be an expansive infrastructure services group focusing on small to medium sized civil engineering and transmission infrastructure projects and services across a wide range of sectors including water works, road works, energy works and data centers.  The companies have an impressive history of strong growth and a proven ability to gain additional market shares in fast-growing areas of the market. The new Eleda group had a combined turnover of ca SEK 6 billion in 2019.

The transaction is subject to customary regulatory approvals.

Vinge’s team consisted of partner Christina Kokko together with associates Manne Bergström, Michaela Cronemyr, Johanna Wiberg, Fredric Reissmüller, Hanna Risberg, Stina Bengtsson and Jonathan Riddersholm (M&A), Trine Osen Bergqvist, Xandra Ståhlberg and Lisa Malmborg (Competition), Josefine Lanker (Banking and Finance), Jessica Öijer and Christoffer Widström (VDR Specialists) and Nathalie Hughes (VDR Assistant).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025